Travis Gerke

Zitiert von

	Alle	Seit 2019
Zitate	2680	2251
h-index	28	25
i10-index	52	50

560

280

140

420

201420152016201720182019202020212022202320248 35 64 134 164 238 338 489 541 460 173

Öffentlicher Zugriff

Alle anzeigen

81 Artikel

1 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Lorelei MucciHarvard TH Chan School of Public HealthBestätigte E-Mail-Adresse bei hsph.harvard.edu
Jennifer R RiderConcertAIBestätigte E-Mail-Adresse bei concertai.com
Svitlana TyekuchevaResearch Scientist, Dana-Farber Cancer InstituteBestätigte E-Mail-Adresse bei dfci.harvard.edu
Konrad H. StopsackMassachusetts General Hospital/Harvard Medical School, Harvard T.H. Chan School of Public HealthBestätigte E-Mail-Adresse bei mail.harvard.edu
Michelangelo FiorentinoChief Molecular Oncologic Pathology, S.Orsola-Malpighi HospitalBestätigte E-Mail-Adresse bei aosp.bo.it
Kosj YamoahMoffitt Cancer Center & Research Institute, University of South FloridaBestätigte E-Mail-Adresse bei moffitt.org
Shivanshu AwasthiH Lee Moffitt Cancer CenterBestätigte E-Mail-Adresse bei moffitt.org
Jennifer Anne SinnottAssociate Professor of Statistics, The Ohio State UniversityBestätigte E-Mail-Adresse bei stat.osu.edu
Jordan CreedMoffitt Cancer CenterBestätigte E-Mail-Adresse bei moffitt.org
Jong Y ParkMoffitt Cancer Center/University of South FloridaBestätigte E-Mail-Adresse bei moffitt.org
Anders BerglundMoffitt Cancer CenterBestätigte E-Mail-Adresse bei moffitt.org
Giovanni ParmigianiProfessor Department of Data Science, DFCIBestätigte E-Mail-Adresse bei dfci.harvard.edu
Mark A. PrestonBrigham and Women's Hospital/Dana Farber Cancer InstituteBestätigte E-Mail-Adresse bei bwh.harvard.edu
Rachel S KellyAssistant Professor of Medicine, Channing Division of Network Medicine, Brigham and Womens HospitalBestätigte E-Mail-Adresse bei channing.harvard.edu
Andrew VickersMemorial Sloan Kettering Cancer CenterBestätigte E-Mail-Adresse bei mskcc.org
Tamara LotanProfessor and Deputy Director for Research, Department of Pathology, Johns Hopkins UniversityBestätigte E-Mail-Adresse bei jhmi.edu
Peter KraftHarvard T.H. Chan School of Public HealthBestätigte E-Mail-Adresse bei hsph.harvard.edu
Daniel D. SjobergMemorial Sloan Kettering Cancer CenterBestätigte E-Mail-Adresse bei mskcc.org
Sara LindströmResearch Scientist, Harvard School of Public HealthBestätigte E-Mail-Adresse bei hsph.harvard.edu

Folgen

Travis Gerke

Director of Data Science, PCCTC

Bestätigte E-Mail-Adresse bei mail.harvard.edu - Startseite

Data Science Molecular Epidemiology Biostatistics Informatics Prostate Cancer


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer TU Ahearn, A Pettersson, EM Ebot, T Gerke, RE Graff, CL Morais, ... Journal of the National Cancer Institute 108 (2), djv346, 2016	201	2016
Association of prostate cancer risk variants with gene expression in normal and tumor tissue KL Penney, JA Sinnott, S Tyekucheva, T Gerke, IM Shui, P Kraft, ... Cancer epidemiology, biomarkers & prevention 24 (1), 255-260, 2015	150	2015
A novel mechanism driving poor-prognosis prostate cancer: overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2) YZ Mazzu, J Armenia, G Chakraborty, Y Yoshikawa, SAA Coggins, ... Clinical Cancer Research 25 (14), 4480-4492, 2019	119	2019
Family history of breast or prostate cancer and prostate cancer risk L Barber, T Gerke, SC Markt, SF Peisch, KM Wilson, T Ahearn, ... Clinical Cancer Research 24 (23), 5910-5917, 2018	119	2018
Aneuploidy drives lethal progression in prostate cancer KH Stopsack, CA Whittaker, TA Gerke, M Loda, PW Kantoff, LA Mucci, ... Proceedings of the National Academy of Sciences 116 (23), 11390-11395, 2019	116	2019
Cholesterol uptake and regulation in high-grade and lethal prostate cancers KH Stopsack, TA Gerke, O Andrén, SO Andersson, EL Giovannucci, ... Carcinogenesis 38 (8), 806-811, 2017	115	2017
Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium IM Shui, S Lindström, AS Kibel, SI Berndt, D Campa, T Gerke, KL Penney, ... European urology 65 (6), 1069-1075, 2014	109	2014
Baseline prostate-specific antigen levels in midlife predict lethal prostate cancer MA Preston, JL Batista, KM Wilson, SV Carlsson, T Gerke, DD Sjoberg, ... Journal of Clinical Oncology 34 (23), 2705, 2016	98	2016
Effects of tobacco smoking on the tumor immune microenvironment in head and neck squamous cell carcinoma JV de la Iglesia, RJC Slebos, L Martin-Gomez, X Wang, JK Teer, AC Tan, ... Clinical Cancer Research 26 (6), 1474-1485, 2020	81	2020
Perineural invasion and risk of lethal prostate cancer P Zareba, R Flavin, M Isikbay, JR Rider, TA Gerke, S Finn, A Pettersson, ... Cancer Epidemiology, Biomarkers & Prevention 26 (5), 719-726, 2017	76	2017
Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation R Brady-Nicholls, JD Nagy, TA Gerke, T Zhang, AZ Wang, J Zhang, ... Nature communications 11 (1), 1750, 2020	73	2020
Cholesterol metabolism and prostate cancer lethality KH Stopsack, TA Gerke, JA Sinnott, KL Penney, S Tyekucheva, HD Sesso, ... Cancer research 76 (16), 4785-4790, 2016	70	2016
Prognostic utility of a new mRNA expression signature of Gleason score JA Sinnott, SF Peisch, S Tyekucheva, T Gerke, R Lis, JR Rider, ... Clinical Cancer Research 23 (1), 81-87, 2017	67	2017
ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D K Komura, Y Yoshikawa, T Shimamura, G Chakraborty, TA Gerke, ... The Journal of clinical investigation 128 (7), 2979-2995, 2018	59	2018
Circulating vitamin D, vitamin D–related genetic variation, and risk of fatal prostate cancer in the N ational C ancer I nstitute B reast and P rostate C ancer C ohort C onsortium IM Shui, AM Mondul, S Lindström, KK Tsilidis, RC Travis, T Gerke, ... Cancer 121 (12), 1949-1956, 2015	59	2015
Molecular differences in transition zone and peripheral zone prostate tumors JA Sinnott, JR Rider, J Carlsson, T Gerke, S Tyekucheva, KL Penney, ... Carcinogenesis 36 (6), 632-638, 2015	53	2015
Baseline prostate-specific antigen level in midlife and aggressive prostate cancer in black men MA Preston, T Gerke, SV Carlsson, L Signorello, DD Sjoberg, SC Markt, ... European urology 75 (3), 399-407, 2019	52	2019
MatSurv: Survival analysis and visualization in MATLAB JH Creed, TA Gerke, AE Berglund Journal of Open Source Software 5 (46), 1830, 2020	49	2020
Prostate cancer racial disparities: a systematic review by the prostate cancer foundation panel BA Mahal, T Gerke, S Awasthi, HR Soule, JW Simons, A Miyahira, ... European urology oncology 5 (1), 18-29, 2022	47	2022
Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease TU Ahearn, S Peisch, A Pettersson, EM Ebot, CK Zhou, RE Graff, ... Carcinogenesis 39 (12), 1431-1437, 2018	46	2018

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren